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The year 2018 saw the advent of what has long been con-
sidered the ultimate taboo: the birth of gene-edited human
babies. The two Chinese girls are supposed to be resistant
to human immunodeficiency virus (HIV) – a feature their
offspring would inherit. The international reaction was re-
markably homogeneous in pointing to the pending confir-
mation of the scientific achievement, in condemning the
experiment as premature at the least and in calling for an
ethical debate before further advances are undertaken.
Since then, the scientist who gene-edited the twins has
been sent to jail. Doubts have been raised not only about
the risks but also about the intended medical benefits. But
even if the experiment may have failed at many levels –
scientifically, clinically and ethically – the aftershock is
still noticeable. It is no exaggeration to say that the world
has become a slightly different place: Editing our own
species is no longer a distant possibility, it is just around
the corner.
Around the time when the birth of the twins was an-
nounced, we were discussing a paper in our PhD student
seminar, a surprisingly simple polemic by a popular psy-
chologist [1]. The primary moral goal for today’s bioethics,
it stated, could be summarised in a single sentence: “Get
out of the way.” Bioethics was depicted as a nuisance that
should not be allowed to impede the dynamic advances of
the new technological wonderworks that will make us hap-
py and rich. Imagine how much money will go to waste
with every day a technology is not yet available, how much
avoidable misery a day of moral deliberation will cost!
The paper is neither particularly innovative nor convinc-
ing, but it is useful for teaching and it did make some
waves [2–4]. And the message that we should not bother
to stop and think is as tempting as it is dangerous – partic-
ularly in times of major technological breakthroughs like
Crispr – so it is worthwhile engaging. Our students were
quick to identify the limits of the claim that technology is
best left alone:
– As serious researchers are first to acknowledge, not
everything is perfect in the world of science and tech-
nology. Abuse does happen, and we would like to have
a shared understanding of what constitutes abuse and
how it should be sanctioned.
– Secondly, the fact that we are using technologies in ben-
eficial ways cannot serve as proof that all is fine as long
as you keep bioethics out of the game. On the contrary,
it speaks to our ability to define ethical rules that serve
us well.
– And finally, it is sometimes not obvious what would
constitute a benefit rather than a threat. Offering well-
reasoned distinctions of what is acceptable and what is
not and helping translate them into policy is a core task
of bioethics.
Just like in science, there may be different views on where
the line should be drawn, and positions may evolve over
time. But this does not render the exercise futile or incred-
ible. Bioethics is not about claiming to know what is right
and wrong and to impose this on others. It is not about
saying no for no reason. Rather, it is about producing and
probing arguments in the light of empirical information.
This task of continuously figuring out what to do with our
technological possibilities cannot be left to scientists or to
consumers alone. The gene-editing experiments are a case
in point that we cannot simply rely on research partici-
pants’ more or less informed consent. Rather, defining how
we choose to employ technologies towards our ends is a
societal responsibility, to which bioethicists can contribute
as catalysts. Ideally, this discourse would not be about hi-
erarchies, dominance and exclusive access to knowledge.
It would be about a multilateral exchange of arguments at
eye level, and about the force of the better argument [5].
We need to mature along with our scientific discoveries,
defining in what way we wish to use them. In our pluralist
societies this process takes time and effort. It is laborious
and messy. But only then can we claim to master technolo-
gies rather than being overwhelmed by them. In order to
support this process, bioethics should not get out of the
way − on the contrary, it should get viral. In order to ap-
proach fundamental questions such as the permissibility
of germline editing, we need conversations involving not
only scientists and other experts but citizens around the
globe. There is no simple way to figure out what the right
thing is to do. It is an effort, and it needs to be a joint effort
as the consequences may well affect the future of humani-
ty.
Taking the time to stop and think about where we want to
go is not a nuisance, it is a necessity.
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